SGLT-2 Inhibitor and GLP-1 Receptor Agonist Prescribing Trends 2015-2020
PCPs and internists accounted nationally for 57% of SGLT2i and 52% of GLP1RA prescriptions in 2020, more than any other specialty, according to new research.
Detox, Withdrawal, Rehab, Relapse: The Experience of Heavy Drinkers
Approximately one-third of survey respondents with AUD relapsed within 1 year of stopping. Find a profile here of the experience of recovery from those who are trying.
Heavy Drinkers Report Impact of Alcohol Use: The Recovery Village Survey Highlights
More than one-third of survey respondents began drinking before age 15; the heaviest drinkers had double the risk for cirrhosis, CVD, pancreatitis, and neuropathy.
7 Questions on Latest US STD Trends
SAMPLE: Between 2019 and 2020, the rate of reported gonorrhea increased 10%. True or false? Plus, 6 more questions based on the CDC’s 2020 STD Surveillance Report.
New AHA Statement on NAFLD and Cardiovascular Risk: A Guideline Topline
NAFLD is a key risk factor for ASCVD and widely underdiagnosed. This Guideline Topline summarizes new AHA warnings, guidance.
Chronic Pain Management in America: A 10-question Quiz
A cross-sectional study found that US adults with chronic pain use a variety of pain management techniques, including opioid and nondrug therapies. Key results in this 10-question quiz.
Should Medicare Cover Medical Marijuana: Medicare Recipients Respond
Medical cannabis is already popular with Medicare recipients and many fear insurance coverage will drive up the cost. Find out what else a new survey found.
Diabetes Technology Myths & Facts for Primary Care Practitioners
Initiating diabetes technology of any kind is a big step for patients, but also for a lot of primary care clinicians. If you have concerns, these myths and facts are for you.
7 New Drugs Approved for Primary Care: Q1 2022
Another new COVID-19 vaccine, the first and only once-daily amphetamine transdermal patch approved for the treatment of ADHD, and 5 more.
ACC, AHA, HFSA 2022 Heart Failure Management Guidelines: A Guideline Topline
The new HF guidelines prioritize primary prevention, revise disease stages to encourage early intervention, and now include SGLT2i as guideline-directed medical therapy.
Patient Education via Mobile Apps: 5 Clinical Considerations
To recommend, or not recommend: that is the question clinicians may ponder when considering education-focused apps for patients. Here, 5 points to help decide.
Coffee and Cardiovascular Health: Is There a Benefit?
ACC 2022. Can a couple of cups of coffee per day keep cardiovascular disease at bay? Findings from 3 new studies shed light.
American College of Cardiology 71st Scientific Sessions: Science Preview, April 2, 2022
ACC 2022. ACC late-breaking clinical trial sessions begin Sat, April 2, 2022. Our short slide shows highlight the studies of interest to primary care clinicians.
American College of Cardiology 71st Scientific Sessions: Science Preview, April 4, 2022
At ACC 2022 on Sunday, 4-2, look for studies on icosapent ethyl and alirocumab, landmark research on HFrEF, and a novel anticoagulant for atrial fibrillation.
American College of Cardiology 71st Scientific Sessions: Science Preview, April 3, 2022
Tobacco Product Use among US Adults: Update on Latest CDC Data
US adults smoked less cigarettes in 2020 than in 2019, but a diverse landscape of tobacco product use persists, according to latest findings released by the CDC.
America's Place in Primary Care: US Ranks Low Among Wealthy Nations
"Exhibit 1. US adults are among the least likely to have a regular doctor or place to go for care." More findings from a Commonwealth Fund report follow.
Telehealth Secures Foothold but Virtual Care Needs Work, Survey Finds
COVID-19 accelerated telehealth as a standard option but what services will it be best suited for now? A new survey suggests the future.
Best & Worst States for Health Care
Which state has the most physicians per capita? Or the highest infant mortality rate? Answers plus more state rankings in our latest slideshow.
10 Questions on Migraine Impact, Diagnosis, & Treatment Based on the OVERCOME Study
Lifetime use of opioids for migraine was found to be higher than for triptan medications. Try these 10 questions on other OVERCOME findings.